<?xml version="1.0" ?>
<proxyVoteTable xmlns="http://www.sec.gov/edgar/document/npxproxy/informationtable">
  <proxyTable>
    <issuerName>GINKGO BIOWORKS HOLDINGS, INC.</issuerName>
    <cusip>37611X100</cusip>
    <isin>US37611X1000</isin>
    <meetingDate>08/14/2024</meetingDate>
    <voteDescription>To approve Article V, Section 1(c) of the Company's Amended and Restated Charter to effect, at the discretion of the Board, a reverse stock split of the issued &amp; outstanding shares of Class A and Class B common stock, which would combine a whole number of outstanding shares of the Class A and Class B common stock in a range of not less than one-for-twenty shares and not more than one-for-forty shares into one share of Class A common stock or Class B common stock, as applicable, and reduce the number of outstanding shares of Class A and Class B common stock.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CAPITAL STRUCTURE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>163472</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>163472</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>GINKGO BIOWORKS HOLDINGS, INC.</issuerName>
    <cusip>37611X100</cusip>
    <isin>US37611X1000</isin>
    <meetingDate>08/14/2024</meetingDate>
    <voteDescription>To approve Article VIII of the Company's Amended and Restated Certificate of Incorporation to permit officer exculpation.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>OTHER</categoryType>
      </voteCategory>
    </voteCategories>
    <otherVoteDescription>Approve Director/Officer Liability and Indemnification</otherVoteDescription>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>163472</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>163472</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>GINKGO BIOWORKS HOLDINGS, INC.</issuerName>
    <cusip>37611X100</cusip>
    <isin>US37611X1000</isin>
    <meetingDate>08/14/2024</meetingDate>
    <voteDescription>To approve the Company's Amended and Restated Certificate of Incorporation, which has been updated to, among other things, remove provisions related to our merger with Soaring Eagle Acquisition Corp. and our domestication process, which are no longer relevant to our business.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>EXTRAORDINARY TRANSACTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>163472</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>163472</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>RECURSION PHARMACEUTICALS, INC.</issuerName>
    <cusip>75629V104</cusip>
    <isin>US75629V1044</isin>
    <meetingDate>11/12/2024</meetingDate>
    <voteDescription>To approve the issuance of shares of Class A Common Stock of Recursion Pharmaceuticals, Inc. (&quot;Recursion&quot;) in connection with Recursion's acquisition of the entire issued and to be issued share capital of Exscientia plc pursuant to a scheme of arrangement under Part 26 of the United Kingdom Companies Act 2006, for purposes of complying with the applicable provisions of the Nasdaq Listing Rules (the &quot;Recursion Share Issuance Proposal&quot;).</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CAPITAL STRUCTURE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>125321</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>125321</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>RECURSION PHARMACEUTICALS, INC.</issuerName>
    <cusip>75629V104</cusip>
    <isin>US75629V1044</isin>
    <meetingDate>11/12/2024</meetingDate>
    <voteDescription>To approve any motion to adjourn the special meeting of stockholders of Recursion (the &quot;Recursion Special Meeting&quot;) to another time or place, if necessary or appropriate, including to solicit additional proxies if there are insufficient votes at the time of the Recursion Special Meeting to approve the Recursion Share Issuance Proposal.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CORPORATE GOVERNANCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>125321</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>125321</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ARCHER AVIATION INC.</issuerName>
    <cusip>03945R102</cusip>
    <isin>US03945R1023</isin>
    <meetingDate>12/20/2024</meetingDate>
    <voteDescription>Approval of an amendment to our amended and restated certificate of incorporation to increase the number of authorized shares of Class A Common Stock.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CAPITAL STRUCTURE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>67152</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>67152</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ARCHER AVIATION INC.</issuerName>
    <cusip>03945R102</cusip>
    <isin>US03945R1023</isin>
    <meetingDate>12/20/2024</meetingDate>
    <voteDescription>Approval of the issuance of Class A Common Stock pursuant to the Stellantis Subscription Agreement and the issuance of Class A Common Stock pursuant to the Stellantis Forward Issuance Agreement and the Stellantis Warrants in accordance with the listing rules of the NYSE.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CAPITAL STRUCTURE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>67152</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>67152</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ARCHER AVIATION INC.</issuerName>
    <cusip>03945R102</cusip>
    <isin>US03945R1023</isin>
    <meetingDate>12/20/2024</meetingDate>
    <voteDescription>Approval of an amendment to our amended and restated certificate of incorporation to add certain foreign ownership limitations to establish restrictions imposed by federal law related to U.S. air carriers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CORPORATE GOVERNANCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>67152</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>67152</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ARCHER AVIATION INC.</issuerName>
    <cusip>03945R102</cusip>
    <isin>US03945R1023</isin>
    <meetingDate>12/20/2024</meetingDate>
    <voteDescription>Approval of an adjournment of the Special Meeting, if necessary and appropriate, to permit further solicitation and vote of proxies.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CORPORATE GOVERNANCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>67152</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>67152</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>TWIST BIOSCIENCE CORPORATION</issuerName>
    <cusip>90184D100</cusip>
    <isin>US90184D1000</isin>
    <meetingDate>02/05/2025</meetingDate>
    <voteDescription>Election of Director: Nelson Chan</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>9219</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>9219</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>TWIST BIOSCIENCE CORPORATION</issuerName>
    <cusip>90184D100</cusip>
    <isin>US90184D1000</isin>
    <meetingDate>02/05/2025</meetingDate>
    <voteDescription>Election of Director: Robert Ragusa</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>9219</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>9219</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>TWIST BIOSCIENCE CORPORATION</issuerName>
    <cusip>90184D100</cusip>
    <isin>US90184D1000</isin>
    <meetingDate>02/05/2025</meetingDate>
    <voteDescription>Election of Director: Melissa Starovasnik</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>9219</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>9219</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>TWIST BIOSCIENCE CORPORATION</issuerName>
    <cusip>90184D100</cusip>
    <isin>US90184D1000</isin>
    <meetingDate>02/05/2025</meetingDate>
    <voteDescription>To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named Executive Officers, as described in the Proxy Statement under &quot;Executive Compensation.&quot;</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>9219</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>9219</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>TWIST BIOSCIENCE CORPORATION</issuerName>
    <cusip>90184D100</cusip>
    <isin>US90184D1000</isin>
    <meetingDate>02/05/2025</meetingDate>
    <voteDescription>To ratify the appointment of Ernst &amp; Young LLP as the independent registered public accounting firm for the fiscal year ending September 30, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>9219</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>9219</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>TWIST BIOSCIENCE CORPORATION</issuerName>
    <cusip>90184D100</cusip>
    <isin>US90184D1000</isin>
    <meetingDate>02/05/2025</meetingDate>
    <voteDescription>To approve an amendment and restatement of the Company's 2018 Equity Incentive Plan (the &quot;EIP&quot;) to increase the number of shares of common stock reserved for issuance of awards under the EIP, eliminate the &quot;evergreen&quot; provision and make other amendments.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>9219</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>9219</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>TWIST BIOSCIENCE CORPORATION</issuerName>
    <cusip>90184D100</cusip>
    <isin>US90184D1000</isin>
    <meetingDate>02/05/2025</meetingDate>
    <voteDescription>To approve an amendment to the Company's Amended and Restated Certificate of Incorporation (the &quot;Charter&quot;) to increase the number of shares of common stock of the Company authorized thereunder by an additional 100,000,000 shares.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CAPITAL STRUCTURE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>9219</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>9219</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>TWIST BIOSCIENCE CORPORATION</issuerName>
    <cusip>90184D100</cusip>
    <isin>US90184D1000</isin>
    <meetingDate>02/05/2025</meetingDate>
    <voteDescription>To approve an amendment to the Charter to provide for officer exculpation.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>OTHER</categoryType>
      </voteCategory>
    </voteCategories>
    <otherVoteDescription>Approve Director/Officer Liability and Indemnification</otherVoteDescription>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>9219</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>9219</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>TERADYNE, INC.</issuerName>
    <cusip>880770102</cusip>
    <isin>US8807701029</isin>
    <meetingDate>05/09/2025</meetingDate>
    <voteDescription>Election of Director to serve as director for a one-year term: Peter Herweck</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>5528</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>5528</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>TERADYNE, INC.</issuerName>
    <cusip>880770102</cusip>
    <isin>US8807701029</isin>
    <meetingDate>05/09/2025</meetingDate>
    <voteDescription>Election of Director to serve as director for a one-year term: Mercedes Johnson</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>5528</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>5528</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>TERADYNE, INC.</issuerName>
    <cusip>880770102</cusip>
    <isin>US8807701029</isin>
    <meetingDate>05/09/2025</meetingDate>
    <voteDescription>Election of Director to serve as director for a one-year term: Ernest E. Maddock</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>5528</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>5528</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>TERADYNE, INC.</issuerName>
    <cusip>880770102</cusip>
    <isin>US8807701029</isin>
    <meetingDate>05/09/2025</meetingDate>
    <voteDescription>Election of Director to serve as director for a one-year term: Marilyn Matz</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>5528</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>5528</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>TERADYNE, INC.</issuerName>
    <cusip>880770102</cusip>
    <isin>US8807701029</isin>
    <meetingDate>05/09/2025</meetingDate>
    <voteDescription>Election of Director to serve as director for a one-year term: Gregory S. Smith</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>5528</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>5528</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>TERADYNE, INC.</issuerName>
    <cusip>880770102</cusip>
    <isin>US8807701029</isin>
    <meetingDate>05/09/2025</meetingDate>
    <voteDescription>Election of Director to serve as director for a one-year term: Paul J. Tufano</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>5528</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>5528</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>TERADYNE, INC.</issuerName>
    <cusip>880770102</cusip>
    <isin>US8807701029</isin>
    <meetingDate>05/09/2025</meetingDate>
    <voteDescription>Election of Director to serve as director for a one-year term: Bridget van Kralingen</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>5528</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>5528</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>TERADYNE, INC.</issuerName>
    <cusip>880770102</cusip>
    <isin>US8807701029</isin>
    <meetingDate>05/09/2025</meetingDate>
    <voteDescription>To approve, on a non-binding, advisory basis, the 2024 compensation of the Company's named executive officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>5528</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>5528</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>TERADYNE, INC.</issuerName>
    <cusip>880770102</cusip>
    <isin>US8807701029</isin>
    <meetingDate>05/09/2025</meetingDate>
    <voteDescription>To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>5528</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>5528</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>TERADYNE, INC.</issuerName>
    <cusip>880770102</cusip>
    <isin>US8807701029</isin>
    <meetingDate>05/09/2025</meetingDate>
    <voteDescription>To approve an amendment and restatement of the Equity and Cash Compensation Incentive Plan.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>5528</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>5528</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>TERADYNE, INC.</issuerName>
    <cusip>880770102</cusip>
    <isin>US8807701029</isin>
    <meetingDate>05/09/2025</meetingDate>
    <voteDescription>To vote on a shareholder proposal requiring the Company to prepare a report about political contributions and expenditures.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>OTHER SOCIAL ISSUES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>SECURITY HOLDER</voteSource>
    <sharesVoted>5528</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>Against</howVoted>
        <sharesVoted>5528</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>DRAFTKINGS INC.</issuerName>
    <cusip>26142V105</cusip>
    <isin>US26142V1052</isin>
    <meetingDate>05/19/2025</meetingDate>
    <voteDescription>Election of Director: Jason D. Robins</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>16011</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>16011</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>DRAFTKINGS INC.</issuerName>
    <cusip>26142V105</cusip>
    <isin>US26142V1052</isin>
    <meetingDate>05/19/2025</meetingDate>
    <voteDescription>Election of Director: Harry E. Sloan</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>16011</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>16011</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>DRAFTKINGS INC.</issuerName>
    <cusip>26142V105</cusip>
    <isin>US26142V1052</isin>
    <meetingDate>05/19/2025</meetingDate>
    <voteDescription>Election of Director: Matthew Kalish</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>16011</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>16011</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>DRAFTKINGS INC.</issuerName>
    <cusip>26142V105</cusip>
    <isin>US26142V1052</isin>
    <meetingDate>05/19/2025</meetingDate>
    <voteDescription>Election of Director: Paul Liberman</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>16011</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>16011</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>DRAFTKINGS INC.</issuerName>
    <cusip>26142V105</cusip>
    <isin>US26142V1052</isin>
    <meetingDate>05/19/2025</meetingDate>
    <voteDescription>Election of Director: Woodrow H. Levin</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>16011</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>16011</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>DRAFTKINGS INC.</issuerName>
    <cusip>26142V105</cusip>
    <isin>US26142V1052</isin>
    <meetingDate>05/19/2025</meetingDate>
    <voteDescription>Election of Director: Jocelyn Moore</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>16011</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>16011</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>DRAFTKINGS INC.</issuerName>
    <cusip>26142V105</cusip>
    <isin>US26142V1052</isin>
    <meetingDate>05/19/2025</meetingDate>
    <voteDescription>Election of Director: Ryan R. Moore</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>16011</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>16011</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>DRAFTKINGS INC.</issuerName>
    <cusip>26142V105</cusip>
    <isin>US26142V1052</isin>
    <meetingDate>05/19/2025</meetingDate>
    <voteDescription>Election of Director: Valerie Mosley</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>16011</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>16011</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>DRAFTKINGS INC.</issuerName>
    <cusip>26142V105</cusip>
    <isin>US26142V1052</isin>
    <meetingDate>05/19/2025</meetingDate>
    <voteDescription>Election of Director: Steven J. Murray</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>16011</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>16011</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>DRAFTKINGS INC.</issuerName>
    <cusip>26142V105</cusip>
    <isin>US26142V1052</isin>
    <meetingDate>05/19/2025</meetingDate>
    <voteDescription>Election of Director: Marni M. Walden</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>16011</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>16011</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>DRAFTKINGS INC.</issuerName>
    <cusip>26142V105</cusip>
    <isin>US26142V1052</isin>
    <meetingDate>05/19/2025</meetingDate>
    <voteDescription>To ratify the appointment of BDO USA, P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>16011</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>16011</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>DRAFTKINGS INC.</issuerName>
    <cusip>26142V105</cusip>
    <isin>US26142V1052</isin>
    <meetingDate>05/19/2025</meetingDate>
    <voteDescription>To conduct a non-binding advisory vote on executive compensation.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>16011</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>16011</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>DRAFTKINGS INC.</issuerName>
    <cusip>26142V105</cusip>
    <isin>US26142V1052</isin>
    <meetingDate>05/19/2025</meetingDate>
    <voteDescription>To consider an amendment to the DraftKings Employee Stock Purchase Plan.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>16011</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>16011</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>DRAFTKINGS INC.</issuerName>
    <cusip>26142V105</cusip>
    <isin>US26142V1052</isin>
    <meetingDate>05/19/2025</meetingDate>
    <voteDescription>To consider a shareholder proposal regarding board matrix disclosure.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CORPORATE GOVERNANCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>SECURITY HOLDER</voteSource>
    <sharesVoted>16011</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>Against</howVoted>
        <sharesVoted>16011</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>TEMPUS AI, INC.</issuerName>
    <cusip>88023B103</cusip>
    <isin>US88023B1035</isin>
    <meetingDate>05/20/2025</meetingDate>
    <voteDescription>Election of Director: Eric Lefkofsky</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>32624</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>32624</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>TEMPUS AI, INC.</issuerName>
    <cusip>88023B103</cusip>
    <isin>US88023B1035</isin>
    <meetingDate>05/20/2025</meetingDate>
    <voteDescription>Election of Director: Peter J. Barris</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>32624</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>32624</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>TEMPUS AI, INC.</issuerName>
    <cusip>88023B103</cusip>
    <isin>US88023B1035</isin>
    <meetingDate>05/20/2025</meetingDate>
    <voteDescription>Election of Director: Eric D. Belcher</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>32624</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>32624</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>TEMPUS AI, INC.</issuerName>
    <cusip>88023B103</cusip>
    <isin>US88023B1035</isin>
    <meetingDate>05/20/2025</meetingDate>
    <voteDescription>Election of Director: Jennifer A. Doudna</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>32624</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>32624</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>TEMPUS AI, INC.</issuerName>
    <cusip>88023B103</cusip>
    <isin>US88023B1035</isin>
    <meetingDate>05/20/2025</meetingDate>
    <voteDescription>Election of Director: David R. Epstein</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>32624</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>32624</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>TEMPUS AI, INC.</issuerName>
    <cusip>88023B103</cusip>
    <isin>US88023B1035</isin>
    <meetingDate>05/20/2025</meetingDate>
    <voteDescription>Election of Director: W.A.I. Frederick, M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>32624</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>32624</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>TEMPUS AI, INC.</issuerName>
    <cusip>88023B103</cusip>
    <isin>US88023B1035</isin>
    <meetingDate>05/20/2025</meetingDate>
    <voteDescription>Election of Director: Scott Gottlieb, M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>32624</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>32624</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>TEMPUS AI, INC.</issuerName>
    <cusip>88023B103</cusip>
    <isin>US88023B1035</isin>
    <meetingDate>05/20/2025</meetingDate>
    <voteDescription>Election of Director: Theodore J. Leonsis</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>32624</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>32624</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>TEMPUS AI, INC.</issuerName>
    <cusip>88023B103</cusip>
    <isin>US88023B1035</isin>
    <meetingDate>05/20/2025</meetingDate>
    <voteDescription>Election of Director: Nadja West, M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>32624</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>32624</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>TEMPUS AI, INC.</issuerName>
    <cusip>88023B103</cusip>
    <isin>US88023B1035</isin>
    <meetingDate>05/20/2025</meetingDate>
    <voteDescription>To ratify the appointment by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>32624</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>32624</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>TEMPUS AI, INC.</issuerName>
    <cusip>88023B103</cusip>
    <isin>US88023B1035</isin>
    <meetingDate>05/20/2025</meetingDate>
    <voteDescription>To approve the reincorporation of the Company from the State of Delaware to the State of Nevada by conversion.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>OTHER</categoryType>
      </voteCategory>
    </voteCategories>
    <otherVoteDescription>Incorporation to another state</otherVoteDescription>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>32624</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>32624</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>PINTEREST, INC.</issuerName>
    <cusip>72352L106</cusip>
    <isin>US72352L1061</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Election of Class III Director to hold office until the 2028 annual meeting and until their successors have been duly elected and qualified, or until their office is otherwise vacated: Leslie Kilgore</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>20994</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>20994</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>PINTEREST, INC.</issuerName>
    <cusip>72352L106</cusip>
    <isin>US72352L1061</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Election of Class III Director to hold office until the 2028 annual meeting and until their successors have been duly elected and qualified, or until their office is otherwise vacated: Bill Ready</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>20994</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>20994</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>PINTEREST, INC.</issuerName>
    <cusip>72352L106</cusip>
    <isin>US72352L1061</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Election of Class III Director to hold office until the 2028 annual meeting and until their successors have been duly elected and qualified, or until their office is otherwise vacated: Benjamin Silbermann</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>20994</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>20994</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>PINTEREST, INC.</issuerName>
    <cusip>72352L106</cusip>
    <isin>US72352L1061</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Election of Class III Director to hold office until the 2028 annual meeting and until their successors have been duly elected and qualified, or until their office is otherwise vacated: Salaam Coleman Smith</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>20994</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>20994</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>PINTEREST, INC.</issuerName>
    <cusip>72352L106</cusip>
    <isin>US72352L1061</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Approve, on a non-binding advisory basis, the compensation of our named executive officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>20994</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>20994</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>PINTEREST, INC.</issuerName>
    <cusip>72352L106</cusip>
    <isin>US72352L1061</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Ratify the audit and risk committee's selection of Ernst &amp; Young LLP as the company's independent registered public accounting firm for fiscal year 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>20994</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>20994</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>PINTEREST, INC.</issuerName>
    <cusip>72352L106</cusip>
    <isin>US72352L1061</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Approve an amendment to our Amended and Restated Certificate of Incorporation to provide for officer exculpation as permitted by Delaware law.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>OTHER</categoryType>
      </voteCategory>
    </voteCategories>
    <otherVoteDescription>Approve Director/Officer Liability and Indemnification</otherVoteDescription>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>20994</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>20994</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ROBLOX CORPORATION</issuerName>
    <cusip>771049103</cusip>
    <isin>US7710491033</isin>
    <meetingDate>05/29/2025</meetingDate>
    <voteDescription>Election of Director: Christopher Carvalho</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>9458</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>9458</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ROBLOX CORPORATION</issuerName>
    <cusip>771049103</cusip>
    <isin>US7710491033</isin>
    <meetingDate>05/29/2025</meetingDate>
    <voteDescription>Election of Director: Gina Mastantuono</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>9458</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>9458</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ROBLOX CORPORATION</issuerName>
    <cusip>771049103</cusip>
    <isin>US7710491033</isin>
    <meetingDate>05/29/2025</meetingDate>
    <voteDescription>Election of Director: Jason Kilar</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>9458</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>9458</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ROBLOX CORPORATION</issuerName>
    <cusip>771049103</cusip>
    <isin>US7710491033</isin>
    <meetingDate>05/29/2025</meetingDate>
    <voteDescription>Advisory Vote on the Compensation of our Named Executive Officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>9458</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>9458</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ROBLOX CORPORATION</issuerName>
    <cusip>771049103</cusip>
    <isin>US7710491033</isin>
    <meetingDate>05/29/2025</meetingDate>
    <voteDescription>Ratification of Independent Registered Public Accounting Firm.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>9458</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>9458</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ROBLOX CORPORATION</issuerName>
    <cusip>771049103</cusip>
    <isin>US7710491033</isin>
    <meetingDate>05/29/2025</meetingDate>
    <voteDescription>Approval of the Reincorporation in Nevada by Conversion.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>OTHER</categoryType>
      </voteCategory>
    </voteCategories>
    <otherVoteDescription>Incorporation to another state</otherVoteDescription>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>9458</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>9458</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>10X GENOMICS, INC.</issuerName>
    <cusip>88025U109</cusip>
    <isin>US88025U1097</isin>
    <meetingDate>06/03/2025</meetingDate>
    <voteDescription>Election of Class III Director to serve a three-year term expiring at the 2028 annual meeting of stockholders or until such director's successors are duly elected and qualified or until such director's earlier death, resignation, disqualification or removal: Sri Kosaraju</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>96720</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>96720</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>10X GENOMICS, INC.</issuerName>
    <cusip>88025U109</cusip>
    <isin>US88025U1097</isin>
    <meetingDate>06/03/2025</meetingDate>
    <voteDescription>Election of Class III Director to serve a three-year term expiring at the 2028 annual meeting of stockholders or until such director's successors are duly elected and qualified or until such director's earlier death, resignation, disqualification or removal: Shehnaaz Suliman</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>96720</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>96720</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>10X GENOMICS, INC.</issuerName>
    <cusip>88025U109</cusip>
    <isin>US88025U1097</isin>
    <meetingDate>06/03/2025</meetingDate>
    <voteDescription>Ratification of the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>96720</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>96720</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>10X GENOMICS, INC.</issuerName>
    <cusip>88025U109</cusip>
    <isin>US88025U1097</isin>
    <meetingDate>06/03/2025</meetingDate>
    <voteDescription>To approve, on a non-binding, advisory basis, the compensation of our named executive officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>96720</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>96720</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>BEAM THERAPEUTICS INC.</issuerName>
    <cusip>07373V105</cusip>
    <isin>US07373V1052</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>Election of Class II Director for three-year terms ending at our Annual Meeting of Stockholders to be held in 2028: Mark Fishman, M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>36860</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>36860</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>BEAM THERAPEUTICS INC.</issuerName>
    <cusip>07373V105</cusip>
    <isin>US07373V1052</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>Election of Class II Director for three-year terms ending at our Annual Meeting of Stockholders to be held in 2028: Carole Ho, M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>36860</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>36860</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>BEAM THERAPEUTICS INC.</issuerName>
    <cusip>07373V105</cusip>
    <isin>US07373V1052</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>Election of Class II Director for three-year terms ending at our Annual Meeting of Stockholders to be held in 2028: Kathleen Walsh</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>36860</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>36860</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>BEAM THERAPEUTICS INC.</issuerName>
    <cusip>07373V105</cusip>
    <isin>US07373V1052</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>Ratify the appointment of Deloitte &amp; Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>36860</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>36860</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>BEAM THERAPEUTICS INC.</issuerName>
    <cusip>07373V105</cusip>
    <isin>US07373V1052</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>Approve, on an advisory basis, the compensation of our named executive officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>36860</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>36860</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>PACIFIC BIOSCIENCES OF CALIFORNIA, INC.</issuerName>
    <cusip>69404D108</cusip>
    <isin>US69404D1081</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>Election of Director: William Ericson</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>197136</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>197136</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>PACIFIC BIOSCIENCES OF CALIFORNIA, INC.</issuerName>
    <cusip>69404D108</cusip>
    <isin>US69404D1081</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>Election of Director: Kathy Ordonez</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>197136</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>197136</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>PACIFIC BIOSCIENCES OF CALIFORNIA, INC.</issuerName>
    <cusip>69404D108</cusip>
    <isin>US69404D1081</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>Election of Director: Christopher M. Smith</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>197136</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>197136</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>PACIFIC BIOSCIENCES OF CALIFORNIA, INC.</issuerName>
    <cusip>69404D108</cusip>
    <isin>US69404D1081</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>To ratify the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for the year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>197136</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>197136</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>PACIFIC BIOSCIENCES OF CALIFORNIA, INC.</issuerName>
    <cusip>69404D108</cusip>
    <isin>US69404D1081</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>To approve, on an advisory basis, the compensation of our named executive officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>197136</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>197136</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>PACIFIC BIOSCIENCES OF CALIFORNIA, INC.</issuerName>
    <cusip>69404D108</cusip>
    <isin>US69404D1081</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>To approve the amendment of our 2020 Equity Incentive Plan.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>197136</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>197136</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>PRIME MEDICINE, INC.</issuerName>
    <cusip>74168J101</cusip>
    <isin>US74168J1016</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>Election of Director: Thomas Cahill, MD, PhD</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>168678</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>168678</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>PRIME MEDICINE, INC.</issuerName>
    <cusip>74168J101</cusip>
    <isin>US74168J1016</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>Election of Director: Robert Nelsen</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>168678</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>168678</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>PRIME MEDICINE, INC.</issuerName>
    <cusip>74168J101</cusip>
    <isin>US74168J1016</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>168678</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>168678</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>CRISPR THERAPEUTICS AG</issuerName>
    <cusip>H17182108</cusip>
    <isin>CH0334081137</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Approval of the Swiss management report, the consolidated financial statements and the statutory financial statements of the Company for the year ended December 31, 2024.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>OTHER</categoryType>
      </voteCategory>
    </voteCategories>
    <otherVoteDescription>Accept Financial Statements and Statutory Reports</otherVoteDescription>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38162</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>38162</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>CRISPR THERAPEUTICS AG</issuerName>
    <cusip>H17182108</cusip>
    <isin>CH0334081137</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Approval of the appropriation of financial results.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>OTHER</categoryType>
      </voteCategory>
    </voteCategories>
    <otherVoteDescription>Accept Financial Statements and Statutory Reports</otherVoteDescription>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38162</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>38162</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>CRISPR THERAPEUTICS AG</issuerName>
    <cusip>H17182108</cusip>
    <isin>CH0334081137</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Discharge of the members of the Board of Directors and the Executive Committee.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CORPORATE GOVERNANCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38162</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>38162</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>CRISPR THERAPEUTICS AG</issuerName>
    <cusip>H17182108</cusip>
    <isin>CH0334081137</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Re-election of Samarth Kulkarni, Ph.D., as member and Chairman</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38162</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>38162</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>CRISPR THERAPEUTICS AG</issuerName>
    <cusip>H17182108</cusip>
    <isin>CH0334081137</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Re-election of Ali Behbahani, M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38162</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>38162</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>CRISPR THERAPEUTICS AG</issuerName>
    <cusip>H17182108</cusip>
    <isin>CH0334081137</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Re-election of Maria Fardis, Ph.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38162</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>38162</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>CRISPR THERAPEUTICS AG</issuerName>
    <cusip>H17182108</cusip>
    <isin>CH0334081137</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Re-election of H. Edward Fleming, Jr., M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38162</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>38162</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>CRISPR THERAPEUTICS AG</issuerName>
    <cusip>H17182108</cusip>
    <isin>CH0334081137</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Re-election of Simeon J. George, M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38162</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>38162</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>CRISPR THERAPEUTICS AG</issuerName>
    <cusip>H17182108</cusip>
    <isin>CH0334081137</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Re-election of John T. Greene</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38162</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>38162</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>CRISPR THERAPEUTICS AG</issuerName>
    <cusip>H17182108</cusip>
    <isin>CH0334081137</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Re-election of Katherine A. High, M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38162</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>38162</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>CRISPR THERAPEUTICS AG</issuerName>
    <cusip>H17182108</cusip>
    <isin>CH0334081137</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Re-election of Sandesh Mahatme, LL.M.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38162</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>38162</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>CRISPR THERAPEUTICS AG</issuerName>
    <cusip>H17182108</cusip>
    <isin>CH0334081137</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Re-election of Christian Rommel, Ph.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38162</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>38162</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>CRISPR THERAPEUTICS AG</issuerName>
    <cusip>H17182108</cusip>
    <isin>CH0334081137</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Re-election of Douglas A. Treco, Ph.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38162</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>38162</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>CRISPR THERAPEUTICS AG</issuerName>
    <cusip>H17182108</cusip>
    <isin>CH0334081137</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Election of Briggs W. Morrison, M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38162</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>38162</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>CRISPR THERAPEUTICS AG</issuerName>
    <cusip>H17182108</cusip>
    <isin>CH0334081137</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Re-election of the member of the Compensation Committee: Ali Behbahani, M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38162</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>38162</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>CRISPR THERAPEUTICS AG</issuerName>
    <cusip>H17182108</cusip>
    <isin>CH0334081137</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Re-election of the member of the Compensation Committee: H. Edward Fleming, Jr., M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38162</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>38162</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>CRISPR THERAPEUTICS AG</issuerName>
    <cusip>H17182108</cusip>
    <isin>CH0334081137</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Re-election of the member of the Compensation Committee: John T. Greene</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38162</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>38162</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>CRISPR THERAPEUTICS AG</issuerName>
    <cusip>H17182108</cusip>
    <isin>CH0334081137</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Election of the member of the Compensation Committee: Briggs W. Morrison, M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38162</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>38162</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>CRISPR THERAPEUTICS AG</issuerName>
    <cusip>H17182108</cusip>
    <isin>CH0334081137</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Binding vote on maximum non- performance-related compensation for members of the Board of Directors from the 2025 Annual General Meeting to the 2026 annual general meeting of shareholders.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38162</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>38162</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>CRISPR THERAPEUTICS AG</issuerName>
    <cusip>H17182108</cusip>
    <isin>CH0334081137</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Binding vote on maximum equity for members of the Board of Directors from the 2025 Annual General Meeting to the 2026 annual general meeting of shareholders.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38162</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>38162</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>CRISPR THERAPEUTICS AG</issuerName>
    <cusip>H17182108</cusip>
    <isin>CH0334081137</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Binding vote on maximum non- performance-related compensation for members of the Executive Committee from July 1, 2025 to June 30, 2026.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38162</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>38162</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>CRISPR THERAPEUTICS AG</issuerName>
    <cusip>H17182108</cusip>
    <isin>CH0334081137</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Binding vote on maximum variable compensation for members of the Executive Committee for the current year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38162</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>38162</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>CRISPR THERAPEUTICS AG</issuerName>
    <cusip>H17182108</cusip>
    <isin>CH0334081137</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Binding vote on maximum equity for members of the Executive Committee from the 2025 Annual General Meeting to the 2026 annual general meeting of shareholders.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38162</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>38162</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>CRISPR THERAPEUTICS AG</issuerName>
    <cusip>H17182108</cusip>
    <isin>CH0334081137</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Non-binding advisory vote on the 2024 Compensation Report.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38162</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>38162</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>CRISPR THERAPEUTICS AG</issuerName>
    <cusip>H17182108</cusip>
    <isin>CH0334081137</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Non-binding advisory vote on the compensation paid to the Company's named executive officers under U.S. securities law requirements.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38162</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>38162</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>CRISPR THERAPEUTICS AG</issuerName>
    <cusip>H17182108</cusip>
    <isin>CH0334081137</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Approval of increasing the maximum size of the Board of Directors.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CORPORATE GOVERNANCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38162</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>38162</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>CRISPR THERAPEUTICS AG</issuerName>
    <cusip>H17182108</cusip>
    <isin>CH0334081137</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Re-election of the independent voting rights representative.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CORPORATE GOVERNANCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38162</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>38162</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>CRISPR THERAPEUTICS AG</issuerName>
    <cusip>H17182108</cusip>
    <isin>CH0334081137</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Re-election of the auditors.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38162</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>38162</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>CRISPR THERAPEUTICS AG</issuerName>
    <cusip>H17182108</cusip>
    <isin>CH0334081137</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Transact any other business that may properly come before the 2025 Annual General Meeting or any adjournment or postponement thereof.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CORPORATE GOVERNANCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38162</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>38162</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>PALANTIR TECHNOLOGIES INC.</issuerName>
    <cusip>69608A108</cusip>
    <isin>US69608A1088</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Election of Director: Alexander Karp</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>8867</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>8867</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>PALANTIR TECHNOLOGIES INC.</issuerName>
    <cusip>69608A108</cusip>
    <isin>US69608A1088</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Election of Director: Stephen Cohen</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>8867</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>8867</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>PALANTIR TECHNOLOGIES INC.</issuerName>
    <cusip>69608A108</cusip>
    <isin>US69608A1088</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Election of Director: Peter Thiel</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>8867</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>8867</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>PALANTIR TECHNOLOGIES INC.</issuerName>
    <cusip>69608A108</cusip>
    <isin>US69608A1088</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Election of Director: Alexander Moore</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>8867</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>8867</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>PALANTIR TECHNOLOGIES INC.</issuerName>
    <cusip>69608A108</cusip>
    <isin>US69608A1088</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Election of Director: Alexandra Schiff</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>8867</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>8867</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>PALANTIR TECHNOLOGIES INC.</issuerName>
    <cusip>69608A108</cusip>
    <isin>US69608A1088</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Election of Director: Lauren Friedman Stat</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>8867</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>8867</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>PALANTIR TECHNOLOGIES INC.</issuerName>
    <cusip>69608A108</cusip>
    <isin>US69608A1088</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Election of Director: Eric Woersching</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>8867</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>8867</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>PALANTIR TECHNOLOGIES INC.</issuerName>
    <cusip>69608A108</cusip>
    <isin>US69608A1088</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Ratification of the appointment of Ernst &amp; Young LLP as Palantir's independent registered public accounting firm for 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>8867</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>8867</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ROKU, INC.</issuerName>
    <cusip>77543R102</cusip>
    <isin>US77543R1023</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Election of Class II Director to serve until the 2028 Annual Meeting of Stockholders: Jeffrey Blackburn</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>7871</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>7871</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ROKU, INC.</issuerName>
    <cusip>77543R102</cusip>
    <isin>US77543R1023</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Election of Class II Director to serve until the 2028 Annual Meeting of Stockholders: Gina Luna</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>7871</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>7871</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ROKU, INC.</issuerName>
    <cusip>77543R102</cusip>
    <isin>US77543R1023</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Election of Class II Director to serve until the 2028 Annual Meeting of Stockholders: Ray Rothrock</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>7871</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>7871</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ROKU, INC.</issuerName>
    <cusip>77543R102</cusip>
    <isin>US77543R1023</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Advisory vote to approve our named executive officer compensation.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>7871</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>7871</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ROKU, INC.</issuerName>
    <cusip>77543R102</cusip>
    <isin>US77543R1023</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Advisory vote to approve the frequency of future advisory votes on our named executive officer compensation.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>7871</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>1 Year</howVoted>
        <sharesVoted>7871</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ROKU, INC.</issuerName>
    <cusip>77543R102</cusip>
    <isin>US77543R1023</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>To ratify the selection of Deloitte &amp; Touche LLP as our independent registered public accounting firm for the year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>7871</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>7871</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ABSCI CORPORATION</issuerName>
    <cusip>00091E109</cusip>
    <isin>US00091E1091</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Election of Class I Director to hold office for a three-year term expiring at our 2028 Annual Meeting of Stockholders or until their respective successors have been duly elected and qualified: Frans van Houten</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>334167</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>334167</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ABSCI CORPORATION</issuerName>
    <cusip>00091E109</cusip>
    <isin>US00091E1091</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Election of Class I Director to hold office for a three-year term expiring at our 2028 Annual Meeting of Stockholders or until their respective successors have been duly elected and qualified: Karen McGinnis</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>334167</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>334167</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ABSCI CORPORATION</issuerName>
    <cusip>00091E109</cusip>
    <isin>US00091E1091</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>To ratify the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm to audit our financial statements for our fiscal year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>334167</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>334167</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>INTELLIA THERAPEUTICS, INC.</issuerName>
    <cusip>45826J105</cusip>
    <isin>US45826J1051</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Election of class III Director to serve until the 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: William Chase</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>41026</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>41026</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>INTELLIA THERAPEUTICS, INC.</issuerName>
    <cusip>45826J105</cusip>
    <isin>US45826J1051</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Election of class III Director to serve until the 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Georgia Keresty, Ph.D., M.P.H.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>41026</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>41026</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>INTELLIA THERAPEUTICS, INC.</issuerName>
    <cusip>45826J105</cusip>
    <isin>US45826J1051</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Election of class III Director to serve until the 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: John M. Leonard, M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>41026</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>41026</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>INTELLIA THERAPEUTICS, INC.</issuerName>
    <cusip>45826J105</cusip>
    <isin>US45826J1051</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Ratification of the appointment of Deloitte &amp; Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>41026</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>41026</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>INTELLIA THERAPEUTICS, INC.</issuerName>
    <cusip>45826J105</cusip>
    <isin>US45826J1051</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Approval, on a non-binding advisory basis, of the compensation of our named executive officers (&quot;NEOs&quot;).</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>41026</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>41026</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>INTELLIA THERAPEUTICS, INC.</issuerName>
    <cusip>45826J105</cusip>
    <isin>US45826J1051</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>A non-binding advisory vote on the frequency of future non-binding advisory votes on the compensation of our NEOs.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>41026</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>1 Year</howVoted>
        <sharesVoted>41026</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>INTELLIA THERAPEUTICS, INC.</issuerName>
    <cusip>45826J105</cusip>
    <isin>US45826J1051</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Approval of the Intellia Therapeutics, Inc. 2025 Equity Incentive Plan.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>41026</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>41026</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>NATERA, INC.</issuerName>
    <cusip>632307104</cusip>
    <isin>US6323071042</isin>
    <meetingDate>06/12/2025</meetingDate>
    <voteDescription>Election of Director: Roy Baynes</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>5803</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>5803</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>NATERA, INC.</issuerName>
    <cusip>632307104</cusip>
    <isin>US6323071042</isin>
    <meetingDate>06/12/2025</meetingDate>
    <voteDescription>Election of Director: Gail Marcus</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>5803</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>5803</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>NATERA, INC.</issuerName>
    <cusip>632307104</cusip>
    <isin>US6323071042</isin>
    <meetingDate>06/12/2025</meetingDate>
    <voteDescription>Election of Director: Ruth Williams-Brinkley</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>5803</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>5803</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>NATERA, INC.</issuerName>
    <cusip>632307104</cusip>
    <isin>US6323071042</isin>
    <meetingDate>06/12/2025</meetingDate>
    <voteDescription>To ratify the appointment of Ernst &amp; Young LLP as Natera, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>5803</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>5803</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>NATERA, INC.</issuerName>
    <cusip>632307104</cusip>
    <isin>US6323071042</isin>
    <meetingDate>06/12/2025</meetingDate>
    <voteDescription>To approve, on an advisory (non- binding) basis, the compensation of Natera, Inc.'s named executive officers as disclosed in the proxy statement.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>5803</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>5803</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>NATERA, INC.</issuerName>
    <cusip>632307104</cusip>
    <isin>US6323071042</isin>
    <meetingDate>06/12/2025</meetingDate>
    <voteDescription>To approve an amendment to Natera's Amended and Restated 2015 Equity Incentive Plan.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>5803</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>5803</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>BLOCK, INC.</issuerName>
    <cusip>852234103</cusip>
    <isin>US8522341036</isin>
    <meetingDate>06/17/2025</meetingDate>
    <voteDescription>Election of Director: JACK DORSEY</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>5921</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>5921</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>BLOCK, INC.</issuerName>
    <cusip>852234103</cusip>
    <isin>US8522341036</isin>
    <meetingDate>06/17/2025</meetingDate>
    <voteDescription>Election of Director: PAUL DEIGHTON</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>5921</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>5921</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>BLOCK, INC.</issuerName>
    <cusip>852234103</cusip>
    <isin>US8522341036</isin>
    <meetingDate>06/17/2025</meetingDate>
    <voteDescription>Election of Director: NEHA NARULA</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>5921</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>5921</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>BLOCK, INC.</issuerName>
    <cusip>852234103</cusip>
    <isin>US8522341036</isin>
    <meetingDate>06/17/2025</meetingDate>
    <voteDescription>TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>5921</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>5921</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>BLOCK, INC.</issuerName>
    <cusip>852234103</cusip>
    <isin>US8522341036</isin>
    <meetingDate>06/17/2025</meetingDate>
    <voteDescription>TO RATIFY THE APPOINTMENT OF ERNST &amp; YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR OUR FISCAL YEAR ENDING DECEMBER 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>5921</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>5921</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>BLOCK, INC.</issuerName>
    <cusip>852234103</cusip>
    <isin>US8522341036</isin>
    <meetingDate>06/17/2025</meetingDate>
    <voteDescription>TO APPROVE THE BLOCK, INC. 2025 EQUITY INCENTIVE PLAN.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>5921</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>5921</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>BLOCK, INC.</issuerName>
    <cusip>852234103</cusip>
    <isin>US8522341036</isin>
    <meetingDate>06/17/2025</meetingDate>
    <voteDescription>TO APPROVE THE BLOCK, INC. AMENDED AND RESTATED 2015 EMPLOYEE STOCK PURCHASE PLAN.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>5921</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>5921</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>SHOPIFY INC.</issuerName>
    <cusip>82509L107</cusip>
    <isin>CA82509L1076</isin>
    <meetingDate>06/17/2025</meetingDate>
    <voteDescription>Election of Director: Tobias Lutke</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>9862</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>9862</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>SHOPIFY INC.</issuerName>
    <cusip>82509L107</cusip>
    <isin>CA82509L1076</isin>
    <meetingDate>06/17/2025</meetingDate>
    <voteDescription>Election of Director: Lulu Cheng Meservey</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>9862</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>9862</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>SHOPIFY INC.</issuerName>
    <cusip>82509L107</cusip>
    <isin>CA82509L1076</isin>
    <meetingDate>06/17/2025</meetingDate>
    <voteDescription>Election of Director: Gail Goodman</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>9862</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>9862</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>SHOPIFY INC.</issuerName>
    <cusip>82509L107</cusip>
    <isin>CA82509L1076</isin>
    <meetingDate>06/17/2025</meetingDate>
    <voteDescription>Election of Director: David Heinemeier Hansson</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>9862</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>9862</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>SHOPIFY INC.</issuerName>
    <cusip>82509L107</cusip>
    <isin>CA82509L1076</isin>
    <meetingDate>06/17/2025</meetingDate>
    <voteDescription>Election of Director: Jeremy Levine</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>9862</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>9862</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>SHOPIFY INC.</issuerName>
    <cusip>82509L107</cusip>
    <isin>CA82509L1076</isin>
    <meetingDate>06/17/2025</meetingDate>
    <voteDescription>Election of Director: Prashanth Mahendra-Rajah</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>9862</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>9862</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>SHOPIFY INC.</issuerName>
    <cusip>82509L107</cusip>
    <isin>CA82509L1076</isin>
    <meetingDate>06/17/2025</meetingDate>
    <voteDescription>Election of Director: Joe Natale</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>9862</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>9862</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>SHOPIFY INC.</issuerName>
    <cusip>82509L107</cusip>
    <isin>CA82509L1076</isin>
    <meetingDate>06/17/2025</meetingDate>
    <voteDescription>Election of Director: Kevin Scott</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>9862</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>9862</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>SHOPIFY INC.</issuerName>
    <cusip>82509L107</cusip>
    <isin>CA82509L1076</isin>
    <meetingDate>06/17/2025</meetingDate>
    <voteDescription>Election of Director: Toby Shannan</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>9862</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>9862</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>SHOPIFY INC.</issuerName>
    <cusip>82509L107</cusip>
    <isin>CA82509L1076</isin>
    <meetingDate>06/17/2025</meetingDate>
    <voteDescription>Election of Director: Fidji Simo</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>9862</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>9862</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>SHOPIFY INC.</issuerName>
    <cusip>82509L107</cusip>
    <isin>CA82509L1076</isin>
    <meetingDate>06/17/2025</meetingDate>
    <voteDescription>Auditor Proposal Resolution approving the reappointment of PricewaterhouseCoopers LLP as the Independent Registered Public Accounting Firm of Shopify Inc. and authorizing the Board of Directors to fix their remuneration.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>9862</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>9862</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>SHOPIFY INC.</issuerName>
    <cusip>82509L107</cusip>
    <isin>CA82509L1076</isin>
    <meetingDate>06/17/2025</meetingDate>
    <voteDescription>Non-binding Advisory Vote on Executive Compensation Non- binding advisory vote that the shareholders accept Shopify Inc.'s approach to executive compensation as disclosed in the Management Information Circular for the Meeting.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>9862</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>9862</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>COINBASE GLOBAL, INC.</issuerName>
    <cusip>19260Q107</cusip>
    <isin>US19260Q1076</isin>
    <meetingDate>06/18/2025</meetingDate>
    <voteDescription>Election of Director: Brian Armstrong</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>3596</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>3596</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>COINBASE GLOBAL, INC.</issuerName>
    <cusip>19260Q107</cusip>
    <isin>US19260Q1076</isin>
    <meetingDate>06/18/2025</meetingDate>
    <voteDescription>Election of Director: Marc L. Andreessen</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>3596</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>3596</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>COINBASE GLOBAL, INC.</issuerName>
    <cusip>19260Q107</cusip>
    <isin>US19260Q1076</isin>
    <meetingDate>06/18/2025</meetingDate>
    <voteDescription>Election of Director: Paul Clement</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>3596</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>3596</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>COINBASE GLOBAL, INC.</issuerName>
    <cusip>19260Q107</cusip>
    <isin>US19260Q1076</isin>
    <meetingDate>06/18/2025</meetingDate>
    <voteDescription>Election of Director: Christa Davies</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>3596</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>3596</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>COINBASE GLOBAL, INC.</issuerName>
    <cusip>19260Q107</cusip>
    <isin>US19260Q1076</isin>
    <meetingDate>06/18/2025</meetingDate>
    <voteDescription>Election of Director: Frederick E. Ehrsam III</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>3596</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>3596</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>COINBASE GLOBAL, INC.</issuerName>
    <cusip>19260Q107</cusip>
    <isin>US19260Q1076</isin>
    <meetingDate>06/18/2025</meetingDate>
    <voteDescription>Election of Director: Kelly A. Kramer</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>3596</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>3596</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>COINBASE GLOBAL, INC.</issuerName>
    <cusip>19260Q107</cusip>
    <isin>US19260Q1076</isin>
    <meetingDate>06/18/2025</meetingDate>
    <voteDescription>Election of Director: Chris Lehane</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>3596</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>3596</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>COINBASE GLOBAL, INC.</issuerName>
    <cusip>19260Q107</cusip>
    <isin>US19260Q1076</isin>
    <meetingDate>06/18/2025</meetingDate>
    <voteDescription>Election of Director: Tobias Lutke</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>3596</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>3596</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>COINBASE GLOBAL, INC.</issuerName>
    <cusip>19260Q107</cusip>
    <isin>US19260Q1076</isin>
    <meetingDate>06/18/2025</meetingDate>
    <voteDescription>Election of Director: Gokul Rajaram</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>3596</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>3596</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>COINBASE GLOBAL, INC.</issuerName>
    <cusip>19260Q107</cusip>
    <isin>US19260Q1076</isin>
    <meetingDate>06/18/2025</meetingDate>
    <voteDescription>Election of Director: Fred Wilson</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>3596</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>3596</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>COINBASE GLOBAL, INC.</issuerName>
    <cusip>19260Q107</cusip>
    <isin>US19260Q1076</isin>
    <meetingDate>06/18/2025</meetingDate>
    <voteDescription>Ratification of the appointment of Deloitte &amp; Touche LLP as our independent registered public accounting firm for the year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>3596</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>3596</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>COINBASE GLOBAL, INC.</issuerName>
    <cusip>19260Q107</cusip>
    <isin>US19260Q1076</isin>
    <meetingDate>06/18/2025</meetingDate>
    <voteDescription>Approval, on a non-binding advisory basis, of the compensation of our named executive officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>3596</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>3596</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>RECURSION PHARMACEUTICALS, INC.</issuerName>
    <cusip>75629V104</cusip>
    <isin>US75629V1044</isin>
    <meetingDate>06/18/2025</meetingDate>
    <voteDescription>Election of Director: Zachary Bogue, J.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>199568</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>199568</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>RECURSION PHARMACEUTICALS, INC.</issuerName>
    <cusip>75629V104</cusip>
    <isin>US75629V1044</isin>
    <meetingDate>06/18/2025</meetingDate>
    <voteDescription>Election of Director: Zavain Dar</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>199568</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>199568</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>RECURSION PHARMACEUTICALS, INC.</issuerName>
    <cusip>75629V104</cusip>
    <isin>US75629V1044</isin>
    <meetingDate>06/18/2025</meetingDate>
    <voteDescription>Election of Director: Robert Hershberg MD PhD</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>199568</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>199568</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>RECURSION PHARMACEUTICALS, INC.</issuerName>
    <cusip>75629V104</cusip>
    <isin>US75629V1044</isin>
    <meetingDate>06/18/2025</meetingDate>
    <voteDescription>Advisory vote to approve executive compensation as disclosed in the 2025 Proxy Statement.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>199568</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>199568</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>RECURSION PHARMACEUTICALS, INC.</issuerName>
    <cusip>75629V104</cusip>
    <isin>US75629V1044</isin>
    <meetingDate>06/18/2025</meetingDate>
    <voteDescription>Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>199568</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>199568</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ROBINHOOD MARKETS, INC.</issuerName>
    <cusip>770700102</cusip>
    <isin>US7707001027</isin>
    <meetingDate>06/25/2025</meetingDate>
    <voteDescription>Election of Director: Vladimir Tenev</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>23980</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>23980</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ROBINHOOD MARKETS, INC.</issuerName>
    <cusip>770700102</cusip>
    <isin>US7707001027</isin>
    <meetingDate>06/25/2025</meetingDate>
    <voteDescription>Election of Director: Baiju Bhatt</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>23980</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>23980</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ROBINHOOD MARKETS, INC.</issuerName>
    <cusip>770700102</cusip>
    <isin>US7707001027</isin>
    <meetingDate>06/25/2025</meetingDate>
    <voteDescription>Election of Director: John Hegeman</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>23980</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>23980</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ROBINHOOD MARKETS, INC.</issuerName>
    <cusip>770700102</cusip>
    <isin>US7707001027</isin>
    <meetingDate>06/25/2025</meetingDate>
    <voteDescription>Election of Director: Paula Loop</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>23980</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>23980</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ROBINHOOD MARKETS, INC.</issuerName>
    <cusip>770700102</cusip>
    <isin>US7707001027</isin>
    <meetingDate>06/25/2025</meetingDate>
    <voteDescription>Election of Director: Meyer Malka</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>23980</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>23980</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ROBINHOOD MARKETS, INC.</issuerName>
    <cusip>770700102</cusip>
    <isin>US7707001027</isin>
    <meetingDate>06/25/2025</meetingDate>
    <voteDescription>Election of Director: Christopher Payne</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>23980</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>23980</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ROBINHOOD MARKETS, INC.</issuerName>
    <cusip>770700102</cusip>
    <isin>US7707001027</isin>
    <meetingDate>06/25/2025</meetingDate>
    <voteDescription>Election of Director: Jonathan Rubinstein</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>23980</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>23980</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ROBINHOOD MARKETS, INC.</issuerName>
    <cusip>770700102</cusip>
    <isin>US7707001027</isin>
    <meetingDate>06/25/2025</meetingDate>
    <voteDescription>Election of Director: Susan Segal</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>23980</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>23980</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ROBINHOOD MARKETS, INC.</issuerName>
    <cusip>770700102</cusip>
    <isin>US7707001027</isin>
    <meetingDate>06/25/2025</meetingDate>
    <voteDescription>Election of Director: Dara Treseder</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>23980</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>23980</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ROBINHOOD MARKETS, INC.</issuerName>
    <cusip>770700102</cusip>
    <isin>US7707001027</isin>
    <meetingDate>06/25/2025</meetingDate>
    <voteDescription>Election of Director: Robert Zoellick</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>23980</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>23980</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ROBINHOOD MARKETS, INC.</issuerName>
    <cusip>770700102</cusip>
    <isin>US7707001027</isin>
    <meetingDate>06/25/2025</meetingDate>
    <voteDescription>To approve, on an advisory basis, the compensation of the Company's named executive officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>23980</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>23980</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ROBINHOOD MARKETS, INC.</issuerName>
    <cusip>770700102</cusip>
    <isin>US7707001027</isin>
    <meetingDate>06/25/2025</meetingDate>
    <voteDescription>To ratify the appointment of Ernst &amp; Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>23980</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>23980</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ARCHER AVIATION INC.</issuerName>
    <cusip>03945R102</cusip>
    <isin>US03945R1023</isin>
    <meetingDate>06/27/2025</meetingDate>
    <voteDescription>Election of Director: Deborah Diaz</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>327143</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>327143</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ARCHER AVIATION INC.</issuerName>
    <cusip>03945R102</cusip>
    <isin>US03945R1023</isin>
    <meetingDate>06/27/2025</meetingDate>
    <voteDescription>Election of Director: Fred Diaz</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>327143</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>327143</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ARCHER AVIATION INC.</issuerName>
    <cusip>03945R102</cusip>
    <isin>US03945R1023</isin>
    <meetingDate>06/27/2025</meetingDate>
    <voteDescription>Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>327143</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>327143</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ARCHER AVIATION INC.</issuerName>
    <cusip>03945R102</cusip>
    <isin>US03945R1023</isin>
    <meetingDate>06/27/2025</meetingDate>
    <voteDescription>Approval, on a non-binding advisory basis, of the compensation of our named executive officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>327143</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>327143</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ARCHER AVIATION INC.</issuerName>
    <cusip>03945R102</cusip>
    <isin>US03945R1023</isin>
    <meetingDate>06/27/2025</meetingDate>
    <voteDescription>Approval of the issuance of Class A Common Stock pursuant to the Stellantis Subscription Agreement.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CAPITAL STRUCTURE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>327143</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>327143</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
</proxyVoteTable>
